GlaxoSmithKline annual Indirect Co2E Emissions - Location-Based Scope 2 from 2016 to 2020 (in kilotonnes)

507 Kt

Indirect Co2E Emissions - Location-Based Scope 2 for the twelve months ending 31 December 2020

GlaxoSmithKline Indirect Co2E Emissions - Location-Based Scope 2 for 12M ended Dec'20 decreased to 507 Kt (-37 /-6.8% y-o-y). Year-over-year, it decreased to 507 Kt (-37 /-6.8% y-o-y). The decline accelerated compared to the CAGR of -4.5% since 4Q'16.

Full time series as generated by EXERICA AI (5 data points have been found in 2 reports from 2016 to 2020)

Date	Indirect Co2E Emissions - Location-Based Scope 2 for 12M ( Kt)	Indirect Co2E Emissions - Location-Based Scope 2 as reported
Dec 2020	507	507
Dec 2019	544	544
Dec 2018	549	549
Dec 2017	605	605
Dec 2016	637	637